A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

NCT00664014 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypovolemic Hyponatremia

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Otsuka Beijing Research Institute

Collaborators

[object Object]